CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
D000614:Aminocaproates; D015119:Aminocaproic Acid; D035843:Biomedical Research; D001797:Blood Protein Electrophoresis; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D004791:Enzyme Inhibitors; D005169:Factor VIII; D005341:Fibrinolysin; D006467:Hemophilia A; D006801:Humans; D010919:Placebos; D010958:Plasminogen; D013223:Statistics as Topic; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014116:Toxicology
D000614:Aminocaproates; D004791:Enzyme Inhibitors; D010919:Placebos; C427184:recombinant factor VIII SQ; D005169:Factor VIII; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; BLOOD PROTEIN ELECTROPHORESIS; CLINICAL RESEARCH; DRUG THERAPY; ENZYME INHIBITORS; FACTOR VIII; FIBRINOLYSIN; HEMOPHILIA; PLACEBOS; PLASMINOGEN; STATISTICS; STREPTODORNASE AND STREPTOKINASE; TOXICOLOGIC REPORT